Navigation Links
New Release of Elekta's Monaco Treatment Planning System Prepares Software for Stereotactic Radiation Therapy
Date:7/18/2011

ATLANTA, July 18, 2011 /PRNewswire/ -- Among the many new features of Monaco® 3.0, Dynamic Conformal Arc (DCA) Therapy provides clinicians with a simple way to deliver highly conformal stereotactic plans by using the multi-leaf collimator (MLC) to dynamically conform around a target as the treatment beam rotates around the patient. DCA recently received 510(k) clearance for Monaco from the U.S. Food and Drug Administration.

"DCA can be used to render more conformal plans by creating multiple arcs in a non-coplanar fashion – in such a way that the geometry of each arc minimizes the dose to the adjacent organs during the gantry rotation," says Todd Powell, Executive Vice President, Elekta Software. "When this technique is used in conjunction with micro-MLCs – such as the new Apex™* MLC, which is now supported in Monaco 3.0 – it can yield very conformal plans and is much easier in terms of quality assurance measurements."

DCA is particularly well-suited for stereotactic treatments because it eliminates the need to modulate the typically higher doses per fraction in stereotactic therapy. DCA's benefit, therefore, is fewer monitor units and reduced treatment time compared with other delivery methods.

"With DCA, clinicians have the option to obtain a comparably conformal plan with approximately half the treatment time and reduced scatter dose," Powell adds.

Monaco 3.0 offers array of stereotactic tools

Streamlining the stereotactic workflow is a major goal of Monaco 3.0, which includes:

  • Apex micro-MLC: 2.5 mm nominal leaf resolution, 12 x 14 cm field size

  • Planning with multiple isocenters: Enables same-fraction, single-plan stereotactic treatment of, e.g., multiple brain mets, multiple brain lesions

  • Plan review and summation for any number of plans

  • Summed dose from multiple plans can be saved into a single plan

  • Sensitivity analysis data table integrated into prescription

  • Workflow-enhancing changes to graphical user interface

  • New dose analysis tools

*Apex is a works in progress and not yet available for sale in the U.S.

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.


'/>"/>
SOURCE Elekta
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Latest Releases of Elektas XiO Planning and Focal Contouring Systems Designed to Increase Efficiency in Planning Therapy for Patients with Cancer
2. Aethlon Medical Releases Shareholder Letter
3. Cardinal Health to Release Fourth-quarter and Full-year Results for Fiscal Year 2011 on Aug. 4
4. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2011 Earnings Release and Conference Call
5. IDEXX Laboratories to Release 2011 Second Quarter Financial Results
6. Now Faster & Easier — Millennium Pharmacy Systems Announces New Release of MPSRx®
7. Life Technologies Sets 2nd Quarter 2011 Earnings Release Date for Thursday, July 28, 2011
8. Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Second Quarter Ended June 30, 2011
9. Hanger Orthopedic Group, Inc. Announces Second Quarter 2011 Earnings Release Conference Call
10. Ascension Orthopedics Announces Market Release of TITAN™ Inset Mini Glenoid
11. Hologic to Release Third Quarter Fiscal 2011 Operating Results on Monday, August 1, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... March 24, 2017 ShangPharma, a ... and cost-effective drug development and discovery services, ... biotechnology industry, announced today the intent for ... will be consolidating the Contract Research Organizations ... Shanghai ChemPartner. These entities include ChemPartner Shanghai, ...
(Date:3/24/2017)... India , March 24, 2017 A ... market has been growing rapidly as the global sales of Adcetris ... the growth in the antibody drug conjugates market is driven by ... of cancer and wider therapeutic window offered by ADCs. ... Browse 3 Tables and 94 ...
(Date:3/24/2017)... , March 24, 2017  Eli Lilly and ... plans to invest $850 million in its U.S. ... across its U.S. enterprise, including research laboratories, manufacturing ... are being driven by demand for Lilly products, ... medicines in development targeting cancer, pain, diabetes and ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... , ... “Vintage and Harvest A Cultivation of Christian Love” is the creation ... North Carolina with his wife, Anna Marie. He and his wife are the proud ... also the author of “Shadow and Substance.” , “Love, the agape kind, is seen ...
(Date:3/23/2017)... ... 2017 , ... In 2016 the World Health Organization declared the Zika virus ... Zika-related cases in the Americas within the next year. Lyme disease is one of ... skyrocketing to an estimated 329,000. Yet, Zika, Lyme and other insect borne illnesses are ...
(Date:3/23/2017)... ... March 23, 2017 , ... Demonstrating ... communities, 16 more public health departments have been awarded national accreditation through the ... million people into the expanding network of communities across the nation whose health ...
(Date:3/23/2017)... ... March 23, 2017 , ... The IoT (Internet of Things) is ... making a huge impact on businesses and individual consumers alike. Laboratories can maximize ... have a value anywhere from $4 trillion to $11 trillion dollars by the year ...
(Date:3/23/2017)... , ... March 23, 2017 ... ... financial services firm serving the families and businesses of the Norwalk and ... program. Northern Ohio Recovery Center (N.O.R.A.) is a nonprofit, community-based substance abuse ...
Breaking Medicine News(10 mins):